Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Aug 5;6:109–116. doi: 10.2147/JAA.S48827

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2013 Diong et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License.

The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.

PMC Copyright notice

Mean forced expiratory volume in 1 second (FEV₁) during the first 180 minutes after inhalation of budesonide/formoterol (pressurized metered-dose inhaler [pMDI] 2 × 160/4.5 mg), salmeterol/fluticasone (pMDI 2 × 25/250 mg), salbutamol (2 × 100 mg), or placebo (percentage increase from predrug value). Copyright © 2001, Elsevier. Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J. Onset of bronchodilation of budesonide/formoterol vs salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther. 2001;14(1):29–34.²